Lantibio-Newsroom Press Releases
Lantibio, Inc. ... AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with ... Lantibio") today announced positive final results from ...{1} Announces The Initiation Of Clinical Trials In Dry Eye Syndrome And ...
Lantibio Inc. ... Lantibio also announced the formation of its scientific advisory board for ... AOP and Lantibio assume no obligation to update any forward ...Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the ...
Further study details as provided by Lantibio: Primary Outcome Measures: ... River Plate Biotechnology, Inc./Lantibio, Inc. ( Terry W. Laliberte/Director of ...Lantibio Inc - Company Profile - BioCentury
Lantibio's detailed financings; Comprehensive pipeline breakdown, including ... www.lantibio.com. Development Status. Phase II (03/07/2007) Archive Items are loading ...Alcon, Lantibio, TRB Chemedica sign licensing agreement for dry eye drug
CHAPEL HILL, N.C. — Lantibio and TRB Chemedica have signed a licensing agreement with a subsidiary of Alcon for the U.S. development, marketing a